We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 24

Joint public meeting to focus on bridging nanotechnology research

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • February 24 2011

The National Nanotechnology Coordination Office has announced that it will spearhead a public meeting to focus on "environmental health and safety questions for nanomaterials and nanotechnology-enabled products" and to "encourage joint US-EU programs of work that would leverage resources."

News bytes

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • December 16 2010

The European Medicines Agency (EMA) adopts two draft guidelines as part of the regulatory approval process for certain biosimilar medicinal products

EU legal services opinion could upset proposed GM laws

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • November 18 2010

According to media sources, the EU Council of Ministers' Legal Service has expressed "strong doubts" about the feasibility of a proposal that would allow individual member states to set their own policies for regulating genetically modified (GM) crops

Report suggests Europe could become marine biotech leader by 2020

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • January 13 2011

The Marine Board of the European Science Foundation has released a report that suggests Europe could become a global leader in marine biotechnology by 2020, particularly by cultivating microalgae for fuel

EU court finds unified patent litigation system incompatible with EU treaties

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • March 24 2011

The Court of Justice of the European Communities has determined that a draft agreement which would create a European and Community Patents Court is not compatible with existing treaties

European Medicines Agency considers changes to biosimilar guidelines

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • October 20 2011

The European Medicines Agency (EMA) has published a concept paper outlining a number of clinical and non-clinical issues that need revision in its current “Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance"

Italy and Spain challenge plans to create unified EU patent protection system

  • Shook Hardy & Bacon LLP
  • -
  • European Union, France, Spain
  • -
  • September 1 2011

Italy and Spain filed applications before the European Court of Justice in early June 2011, seeking to annul the EU Council’s Decision of 10 March 2011, which authorized cooperation among member states for the creation of unitary patent protection

European nations sign MOU to manage life-science information

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • September 22 2011

Denmark, Finland, the Netherlands, Sweden, and the United Kingdom have reportedly signed a memorandum of understanding (MOU) with the European Molecular Biology Laboratory to create an infrastructure that would both manage and safeguard life-science data generated by publicly funded research

European Court of Justice weighs in on GMOs

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • September 22 2011

In recent weeks, the European Court of Justice (ECJ) has issued rulings in two cases involving genetically modified organisms (GMOs

EU Court of Justice interprets law extending patent protection for medicinal products

  • Shook Hardy & Bacon LLP
  • -
  • European Union
  • -
  • December 15 2011

The Court of Justice of the European Union (ECJ) has issued two rulings interpreting EU law at the request of British courts addressing whether drug makers can obtain a supplementary protection certificate (SPC), which extends patent protection, for products with active ingredients additional to those specified in the original patent

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy